Delivery Order SPE2DB22D3401-SPE2DB24FT1XA
Award Date 2/13/24
Potential Completion Date 2/14/24
Potential Value $31K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide STELARA 90 MG/ML SYRINGEML. The $57,189.46 contract has a completion date of March 8, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to supply STELARA 90 MG/ML syringes. The $48,350.93 contract has a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor, with no set-aside designation mentioned. This delivery order is likely part of a larger indefinite delivery contract (IDC) Amerisourcebergen holds with...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide STELARA 90 MG/ML SYRINGEML. The order has a potential value of $64,397.14 and a completion date of March 1, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $44,517.52 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply STELARA 90 MG/ML SYRINGEML pharmaceutical products. The delivery order was issued under an existing contract with the agency to provide pharmaceuticals, medical supplies, and distribution services to support military treatment programs and facilities. Amerisourcebergen Drug Corp has extensive experience as a prime...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of STELARA 90 MG/ML SYRINGE. The award has a potential value of $8,081.84 and a completion date of February 2, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 through December 31, 2025. This IDC serves as the primary...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of STELARA 45 MG/0.5 ML VIAL 0.5ML pharmaceutical products. The contract, valued at $4,571.13, has an ultimate completion date of April 17, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the for-profit Amerisourcebergen Corporation, to provide STELARA 90 MG/ML syringes. The award, valued at $40,294.20, has a completion date of January 31, 2024. This delivery order falls under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and performance through December 31, 2025, which serves as the primary vehicle for...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide STELARA 90 MG/ML syringes. The contract has a ceiling value of $16,101.43 and a period of performance through March 13, 2024. Amerisourcebergen Drug Corp serves as the prime contractor and has an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025 to deliver a...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $42,974.94 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide STELARA 90 MG/ML SYRINGE/ML. The delivery order has a completion date of March 7, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for the company to deliver...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of STELARA 90 MG/ML SYRINGE/ML. The contract has a potential value of $9,066.45 and a completion date of February 27, 2024. Amerisourcebergen Drug Corp, as the prime contractor, is responsible for delivering this pharmaceutical product to support military treatment programs and facilities. This delivery order is issued...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB24FT1XADelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the for-profit organization Amerisourcebergen Corporation, for the supply of STELARA 90 MG/ML SYRINGEML. The $31,425.34 contract has a completion date of February 14, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025 to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This delivery order is issued under that IDC. No set-aside designation was used for this contract.
Generated 5/14/24, 12:06 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.4k | 2/13/24 |